Senores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's website. The IPO saw a robust subscription of over 93.41 times, and shares are expected to list on December 30. Currently, they are trading at a premium of 61% in the grey market.
